Search clinical trials for: Combination of Bendamustine + Dasatinib
Total 5808 results
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Namyi GuUnknownDiabetes MellitusKorea, Republic of
-
AA SecordCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Amsterdam UMC, location VUmcOdense University Hospital; Helsinki University Central Hospital; Aarhus University... and other collaboratorsRecruitingCML, RelapsedDenmark, Norway, Sweden, Netherlands, Finland, France, Germany
-
Bristol-Myers SquibbTerminatedCarcinoma, Non-small Cell LungBrazil, Taiwan, United Kingdom, United States, Canada, Germany, Poland
-
Bristol-Myers SquibbCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveChina
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompleted
-
Duke UniversityBristol-Myers SquibbTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Dana-Farber Cancer InstituteTerminated
-
National Cancer Institute (NCI)CompletedMetastatic Squamous Neck Cancer With Occult Primary | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
State Budgetary Healthcare Institution, National...Enrolling by invitationHemorrhage | Malocclusion | Maxillofacial Injuries | OrthodonticsRussian Federation
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGRecruitingRelapsed or Refractory Hodgkin's LymphomaItaly
-
University of Wisconsin, MadisonGlaxoSmithKlineCompletedMetastatic Colorectal CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Harbin Medical UniversityRecruitingGastrointestinal Cancer | Immunotherapy | Targeted TherapyChina
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Henan Cancer HospitalUnknownAdvanced Cancer | Mucosal Melanoma | Apatinib | SHR-1210China
-
Beijing HospitalJiangsu HengRui Medicine Co., Ltd.UnknownHER-2 Negatived Gastric CancerChina
-
Shanxi Province Cancer HospitalUnknown
-
Zhejiang Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Endometrial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompleted
-
SCRI Development Innovations, LLCSanofi; GlaxoSmithKline; NovartisTerminatedMetastatic Breast Cancer With Intracranial MetastasesUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular Non-Hodgkin's LymphomaItaly
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingTreatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationChina
-
HRYZ Biotech Co.Recruiting
-
Elevar TherapeuticsCompleted
-
Peking University Cancer Hospital & InstituteUnknown
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedA Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)Non-Small Cell Lung CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHepatocellular Carcinoma Resectable
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
Tianjin Medical University Second HospitalUnknownSmall Cell Lung Cancer Extensive StageChina
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International HospitalWithdrawnAdvanced Cancer | Soft Tissue Sarcoma AdultChina
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; United States Department of DefenseCompleted
-
Duke UniversityBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Italy, France
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, Hungary, Belgium, United Kingdom, France, Australia, Turkey, Croatia, Italy, Poland, Canada, Greece, Czechia, Ireland, Russian Federation, Spain, Portugal, Romania
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompleted
-
Noah MerinTeva Branded Pharmaceutical Products R&D, Inc.; Miltenyi Biomedicine GmbHActive, not recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | CLLUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
Fate TherapeuticsTerminatedB-cell Lymphoma | Acute Myelogenous LeukemiaUnited States
-
Columbia UniversityCephalonCompletedAL AmyloidosisUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Merck Sharp & Dohme LLCRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaPoland, Turkey, Denmark, Singapore, Hungary, Hong Kong, Taiwan, Chile, Malaysia, Brazil, Guatemala, China, South Africa, Colombia, United States, Ukraine, Australia, Mexico, Romania
-
CelgeneThe Lymphoma Academic Research OrganisationActive, not recruitingFollicular LymphomaUnited States, Japan